SG11201407089SA - Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition - Google Patents

Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition

Info

Publication number
SG11201407089SA
SG11201407089SA SG11201407089SA SG11201407089SA SG11201407089SA SG 11201407089S A SG11201407089S A SG 11201407089SA SG 11201407089S A SG11201407089S A SG 11201407089SA SG 11201407089S A SG11201407089S A SG 11201407089SA SG 11201407089S A SG11201407089S A SG 11201407089SA
Authority
SG
Singapore
Prior art keywords
irritative
nanoemulsion
cyclosporine
opthalmic composition
opthalmic
Prior art date
Application number
SG11201407089SA
Other languages
English (en)
Inventor
Sung Joo Hwang
Kwang Ho Cha
Han Kang
Bo Kyung Sun
Original Assignee
Univ Yonsei Iacf
Huons Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yonsei Iacf, Huons Co Ltd filed Critical Univ Yonsei Iacf
Publication of SG11201407089SA publication Critical patent/SG11201407089SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biochemistry (AREA)
SG11201407089SA 2012-04-30 2013-01-22 Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition SG11201407089SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120045708A KR101211902B1 (ko) 2012-04-30 2012-04-30 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
PCT/KR2013/000509 WO2013165074A1 (fr) 2012-04-30 2013-01-22 Composition ophtalmique contenant de la cyclosporine sous forme de nanoémulsion non irritante

Publications (1)

Publication Number Publication Date
SG11201407089SA true SG11201407089SA (en) 2014-12-30

Family

ID=47907577

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407089SA SG11201407089SA (en) 2012-04-30 2013-01-22 Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition

Country Status (10)

Country Link
US (1) US9320801B2 (fr)
EP (1) EP2845602B1 (fr)
JP (1) JP5986296B2 (fr)
KR (1) KR101211902B1 (fr)
CN (1) CN104302308B (fr)
AU (1) AU2013255231B2 (fr)
ES (1) ES2651412T3 (fr)
RU (1) RU2578415C1 (fr)
SG (1) SG11201407089SA (fr)
WO (1) WO2013165074A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2887923T1 (sl) 2012-08-24 2023-09-29 Sun Pharmaceutical Industries Limited Oftalmična formulacija polioksilnega lipida ali polioksilne maščobne kisline in zdravljenje očesnih stanj
KR101587412B1 (ko) 2014-10-17 2016-01-21 주식회사 휴온스 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물
US10455242B2 (en) * 2015-03-04 2019-10-22 Qualcomm Incorporated Signaling output indications in codec-hybrid multi-layer video coding
KR101587385B1 (ko) 2015-07-29 2016-01-21 국제약품공업주식회사 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법
FR3041883B1 (fr) * 2015-10-02 2019-03-15 Chu Clermont-Ferrand Procede de preparation d'un collyre de ciclosporine a
RU2747455C2 (ru) * 2016-02-29 2021-05-05 Сан Фарма Глобал Фзе Циклоспорин-содержащие лекарственные формы для наружного применения и их применения
RU2620568C1 (ru) * 2016-04-12 2017-05-26 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПбГПМУ Минздрава России) Препарат для лечения синдрома "сухого глаза"
US10702578B2 (en) 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
CN109010270B (zh) * 2018-09-03 2021-07-30 辅必成(上海)医药科技有限公司 一种阳离子材料制备的眼用乳
WO2021049825A1 (fr) * 2019-09-09 2021-03-18 주식회사태준제약 Composition ophtalmique en nanoémulsion comprenant de la cyclosporine et du menthol, et son procédé de préparation
CN112957450A (zh) * 2019-12-20 2021-06-15 艾棣维欣(苏州)生物制药有限公司 一种难溶性药物的水溶液及其制备方法
TW202402319A (zh) * 2022-03-28 2024-01-16 日商中外製藥股份有限公司 含有包含聚氧乙烯構造的油性成分之化合物製劑

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0558906A (ja) 1991-09-06 1993-03-09 Sankyo Co Ltd シクロスポリン点眼製剤
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
TR199902199T2 (xx) * 1997-03-12 2002-06-21 Abbott Laboratories Siklosporin tatbiki i�in hidrofilik ikili sistemler.
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
AU7638200A (en) * 1999-10-20 2001-04-30 Vesifact Ag Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
KR100669510B1 (ko) 2005-08-17 2007-01-16 보람제약주식회사 사이크로스포린을 함유한 나노 에멀젼 농축액 조성물 및 그제조방법
CN101484138A (zh) * 2006-03-07 2009-07-15 诺瓦瓦克斯有限公司 难溶性药用活性成分的纳米乳液和制备该乳液的方法
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
JP5026824B2 (ja) * 2006-03-10 2012-09-19 マルホ株式会社 シクロスポリンを含有する液晶乳化型医薬組成物
JP5619419B2 (ja) * 2006-09-29 2014-11-05 インファ ソシエテ アノニム 薬学的組成物用調剤システム及び静脈内投与用キット
CN101244256A (zh) * 2007-02-16 2008-08-20 中国科学院上海药物研究所 一种环孢菌素a眼用微/亚微乳原位凝胶制剂及其制备方法
MX340897B (es) * 2007-10-02 2016-07-29 Theranos Inc Dispositivos modulares de punto de cuidado y usos de los mismos.
JP5640207B2 (ja) * 2007-10-08 2014-12-17 セラオプティクスTheraoptics 水性眼用処方物
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
CA2719803A1 (fr) 2008-03-28 2009-10-01 University Of Massachusetts Compositions et procedes de preparation de nanoemulsions
KR101008189B1 (ko) 2010-07-29 2011-01-17 에스씨바이오팜 주식회사 안구건조증 치료용 사이클로스포린 함유 안과용 나노에멀젼 조성물

Also Published As

Publication number Publication date
JP5986296B2 (ja) 2016-09-06
WO2013165074A1 (fr) 2013-11-07
JP2015514800A (ja) 2015-05-21
US9320801B2 (en) 2016-04-26
EP2845602A1 (fr) 2015-03-11
CN104302308A (zh) 2015-01-21
ES2651412T3 (es) 2018-01-26
CN104302308B (zh) 2018-05-29
EP2845602A4 (fr) 2015-12-30
AU2013255231B2 (en) 2015-08-13
KR101211902B1 (ko) 2012-12-13
RU2578415C1 (ru) 2016-03-27
AU2013255231A1 (en) 2014-10-02
EP2845602B1 (fr) 2017-10-11
US20150125494A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
SG11201407089SA (en) Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition
HK1200325A1 (en) Sunscreen composition
HUE041685T2 (hu) 2,3,3,3-Tetrafluor-propént tartalmazó készítmény
GB201304967D0 (en) .
EP2872485A4 (fr) Groupe auxiliaire asymétrique
GB201204183D0 (en) .
HK1200109A1 (en) Ophthalmic composition
HK1207317A1 (en) Substituted 1,6-naphthyridines 16-
HK1200113A1 (en) Ophthalmic composition
ZA201500518B (en) Shampoo composition
IL280316B (en) Amphiphilic compounds, preparations and their use
IL237542A0 (en) Amphiphilic compounds, their preparations and uses
IL237540B (en) Amphiphilic compounds, their preparations and uses
IL237538A0 (en) Amphiphilic compounds, their preparations and uses
IL237539A0 (en) Amphiphilic compounds, their preparations and uses
EP2800573A4 (fr) Composition ophtalmique
EP2903586B8 (fr) Composition
IL233477B (en) Ophthalmic composition
AU2012903414A0 (en) Composition
AU2012902570A0 (en) Composition
GB201207426D0 (en) .
GB201206865D0 (en) .
GB201206866D0 (en) .
GB201205844D0 (en) .
GB201200117D0 (en) .